Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol for small bowel ulcers in aspirin users
NCT01998776Phase 3
Key facts
- Status
- Completed
- Start
- Apr 2013
- Primary completion
- Jan 2018
- Countries
- 2
- Sponsor
- The Chinese University of Hong Kong
- Modality
- Small Molecules
- Drugs
- misoprostol
- Conditions
- duodenal ulcer
01
Overview
Phase 3, randomised, double-blind trial of misoprostol in duodenal ulcer, sponsored by The Chinese University of Hong Kong. Primary endpoint: Complete healing of small bowel ulcers at 8 weeks. Started Apr 2013; status: completed.
02
Design
- Study design
- RandomizedDouble-blind
03
Who it enrols
Adult aspirin users with suspected small bowel overt or occult bleeding and normal upper/lower endoscopy.
04
Endpoints
Primary
Complete healing of small bowel ulcers
Beyond the preview
Go deeper on NCT01998776.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01998776.